Search Results - "The Lancet. Infectious diseases"
-
1
Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation
Published in The Lancet infectious diseases (01-02-2014)“…Summary Background Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe lower respiratory tract infection in people. Previous studies…”
Get full text
Journal Article -
2
Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study
Published in The Lancet infectious diseases (01-10-2011)“…Summary Background The seven-valent pneumococcal conjugate vaccine (PCV7) has reduced vaccine-type (VT) invasive pneumococcal disease but increases in…”
Get full text
Journal Article -
3
Exaggerated risk of transmission of COVID-19 by fomites
Published in The Lancet infectious diseases (01-08-2020)Get full text
Journal Article -
4
Covert COVID-19 and false-positive dengue serology in Singapore
Published in The Lancet infectious diseases (01-05-2020)Get full text
Journal Article -
5
Hendra virus: an emerging paramyxovirus in Australia
Published in The Lancet infectious diseases (01-10-2012)“…Summary Hendra virus, first identified in 1994 in Queensland, is an emerging zoonotic pathogen gaining importance in Australia because a growing number of…”
Get full text
Journal Article -
6
Passive immunity in the prevention of rabies
Published in The Lancet infectious diseases (01-05-2012)“…Summary Prevention of clinical disease in those exposed to viral infection is an important goal of human medicine. Using rabies virus infection as an example,…”
Get full text
Journal Article -
7
Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments
Published in The Lancet infectious diseases (01-12-2004)“…After initial infection, human cytomegalovirus remains in a persistent state with the host. Immunity against the virus controls replication, although…”
Get more information
Journal Article -
8
Does antimalarial mass drug administration increase or decrease the risk of resistance?
Published in The Lancet infectious diseases (01-01-2017)“…Summary All antimalarial drugs developed so far have eventually succumbed to resistance. There is a general belief that the more people that are exposed to an…”
Get full text
Journal Article -
9
Problem pathogens: extra-intestinal complications of Salmonella enterica serotype Typhi infection
Published in The Lancet infectious diseases (01-06-2005)“…Typhoid fever, caused by Salmonella enterica seroptype Typhi (S typhi), has an estimated worldwide prevalence of 12-33 million cases. The pathogenesis of this…”
Get more information
Journal Article -
10
DSM265: a novel drug for single-dose cure of Plasmodium falciparum malaria
Published in The Lancet infectious diseases (01-08-2018)Get full text
Journal Article -
11
Challenges to eliminate rabies virus infection in China by 2020
Published in The Lancet infectious diseases (01-02-2017)“…The high costs and long distance from rural areas to health clinics are reasons for the low proportion of this treatment. Since 2011, rabies cases in people…”
Get full text
Journal Article -
12
Estimates of the severity of coronavirus disease 2019: a model-based analysis
Published in The Lancet infectious diseases (01-06-2020)“…In the face of rapidly changing data, a range of case fatality ratio estimates for coronavirus disease 2019 (COVID-19) have been produced that differ…”
Get full text
Journal Article -
13
Early dynamics of transmission and control of COVID-19: a mathematical modelling study
Published in The Lancet infectious diseases (01-05-2020)“…An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to 95 333 confirmed cases as of March 5, 2020. Understanding the early…”
Get full text
Journal Article -
14
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
Published in The Lancet infectious diseases (01-02-2021)“…With the unprecedented morbidity and mortality associated with the COVID-19 pandemic, a vaccine against COVID-19 is urgently needed. We investigated CoronaVac…”
Get full text
Journal Article -
15
Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study
Published in The Lancet infectious diseases (01-08-2020)“…Rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Wuhan, China, prompted heightened surveillance in Shenzhen, China. The…”
Get full text
Journal Article -
16
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study
Published in The Lancet infectious diseases (01-01-2022)“…The SARS-CoV-2 delta (B.1.617.2) variant was first detected in England in March, 2021. It has since rapidly become the predominant lineage, owing to high…”
Get full text
Journal Article -
17
Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study
Published in The Lancet infectious diseases (01-07-2021)“…The Pfizer-BioNTech (BNT162b2) and the Oxford-AstraZeneca (ChAdOx1 nCoV-19) COVID-19 vaccines have shown excellent safety and efficacy in phase 3 trials. We…”
Get full text
Journal Article -
18
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
Published in The Lancet infectious diseases (01-01-2021)“…The ongoing COVID-19 pandemic warrants accelerated efforts to test vaccine candidates. We aimed to assess the safety and immunogenicity of an inactivated…”
Get full text
Journal Article -
19
Viral dynamics in mild and severe cases of COVID-19
Published in The Lancet infectious diseases (01-06-2020)“…Patients who had any of the following features at the time of, or after, admission were classified as severe cases: (1) respiratory distress (≥30 breaths per…”
Get full text
Journal Article -
20
Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study
Published in The Lancet infectious diseases (01-02-2022)“…The SARS-CoV-2 delta (B.1.617.2) variant is highly transmissible and spreading globally, including in populations with high vaccination rates. We aimed to…”
Get full text
Journal Article